Medafor's Acquisition

Medafor was acquired by C.R. Bard on August 20, 2013.

Medafor develops and markets a breakthrough in hemostatic technology and absorbable hemostats called Microporous Polysaccharide Hemospheres (MPH). Medafor markets the Arista MPH Hemostat, which is ind…

Articles about Medafor's Acquisition: